Industry Supported Session

Lunch ’n Learn: Measuring outcomes that matter to patients in Neuromuscular Disease: An individualized approach to transitioning from IVIg to home based therapy with SCIg

Thursday, June 8, 2023

12:00 PM – 1:30 PM MST

Location:H-M2: Alberta

Audience:

Adult Neurologist, Child Neurologist, Resident, Fellow, Nurses with interest in topic

Learning Level:

Basic (Resident, New Information), Intermediate (Practicing Physician), Advanced (Special Interest, Higher Level Discussion)

Learning Format:

Case studies, Forum/panels, Lecture/plenary method, Question and answer sessions.

CanMEDs Roles:

Medical Expert, Scholar, Communicator, Collaborator, Health Advocate, Professional

Faculty(s)

To help guide shared treatment decision, we will discuss the importance of individualizing the clinical approach and measuring outcomes that matter to patients with neuromuscular disorders. Then we will explore the options how to incorporate these outcome measurements into routine neurology practice. Finally we will understand the principles and practical considerations of transitioning patients with immune mediated neurologic conditions from IVIg to home-based treatment with SCIg.

This program was developed by the CNSF and CSL Behring and was planned to achieve scientific integrity, objectivity and balance. It is an unaccredited learning activity and not eligible for MOC credits.

Learning Objectives:

Understand the importance of measuring outcomes that matter to patients with neuromuscular disorders to guide shared treatment decisions
Incorporate outcome measures into their office practice
Understand the principles and practical considerations of transitioning patients with immune mediated neurologic conditions from IVIg to home-based treatment with SCIg

Presentations:

12:00 PM – 12:05 PM MST

Introduction
Faculty: Shahin Khayambashi
12:05 PM – 12:25 PM MST

Value Based Health Care: Measuring Outcomes That Matter in Neuromuscular Disease
Faculty: Kristine M. Chapman
12:25 PM – 12:50 PM MST

Outcome Measurement Applied to CIDP and MG, and Immunotherapy
Faculty: Katie Beadon
12:50 PM – 1:10 PM MST

Transition to SCIg from IVIg: Practical suggestions and nursing perspective
Faculty: Mairead Ashe
1:10 PM – 1:25 PM MST

Cases and Discussion
Faculty: Kristine M. Chapman
Faculty: Katie Beadon
1:25 PM – 1:30 PM MST

Q and A
Faculty: Shahin Khayambashi